China Pilot of ICOPE (Integrated Care for Older People) in Chaoyang

NCT05933798 | Completed DMC

• 1 other identifier: 2020-QS-001
• Study Type: interventional
• Target: 2,148
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this pilot study is to examine predefined parameters (sample size, capacity building, acceptance by community-dwelling older people (participants) and care providers) to evaluate the feasibility of implementing World Health Organization's ICOPE (integrated care for older people) approach in China. The main questions it aims to answer are:

1. 1.Whether it is feasible to implement the ICOPE approach in China;
2. 2.Whether the integrated care approach would make any difference in health outcomes and resource utilization.

Conditions

Aging; Healthy Aging; Utilization, Health Care

Keywords

integrated care; primary care; ICOPE; decade of healthy ageing

Outcome Measures

Primary Outcomes (1)

• Feasibility of implementing the ICOPE program in China

  1. Sample size (to successfully recruit over 2,000 participants, 500 of whom were to be categorized in the intervention group) 2. Capacity building (at least 200 primary care providers to be fully trained and deployed in the pilot program) 3. Acceptance (reach more than 90% satisfaction with the pilot by both participants and providers).

  12 months

Secondary Outcomes (5)

• Independence

  6 months

• Cognition

  6 months

• Vitality

  6 months

• Mobility

  6 months

• Psychological health

  6 months

Study Arms (2)

Intervention Group

EXPERIMENTAL

Participants who were actively followed up during the study period with a personalized integrated care plan developed following the ICOPE screening and assessment, identified as "at-risk" for loss in intrinsic capacity.

Other: ICOPE

Control Group

ACTIVE COMPARATOR

Pariticpants who continued receiving usual care during the study period.

Other: Usual Care

Interventions

ICOPE OTHER

The ICOPE approach with locally adapted care pathways was implemented by trained integrated care managers (ICMs) advised by multi-disciplinary teams, delivered in primary care settings

Intervention Group

Usual Care OTHER

Participants in the Control Group would have their care plan after assessment and seek health and care services as usual without additional advice or support on implementing the care plan

Control Group

Eligibility Criteria

• Age: 60 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Screened as positive for intrinsic capacity declines
• Decline in intrinsic capacity confirmed by in-depth assessment in any of the domains described as: MMSE \< 27 (for cognition), SPPB ≤ 9 (for locomotion), MNA-SF \<12 (for vitality we used nutrition as a proxy), GDS-5 ≥ 2 (for psychology we used depression as a proxy) or any vision impairment
• Signed form of consent and willingly participate in the pilot study

You may not qualify if:

• Negative results in their intrinsic capacity decline screening
• Severe hearing problems as the study was conducted during COVID-19 pandemics period and relied on telecare or remote sessions of intervention

Sponsors & Collaborators

• Pinetree Health Technologies (Beijing) Co., Ltd.: lead
• Peking Union Medical College Hospital: collaborator

Study Sites (1)

Pinetree Care Group

Beijing, 100029, China

Location

Related Publications (1)

• Tavassoli N, de Souto Barreto P, Berbon C, Mathieu C, de Kerimel J, Lafont C, Takeda C, Carrie I, Piau A, Jouffrey T, Andrieu S, Nourhashemi F, Beard JR, Soto Martin ME, Vellas B. Implementation of the WHO integrated care for older people (ICOPE) programme in clinical practice: a prospective study. Lancet Healthy Longev. 2022 Jun;3(6):e394-e404. doi: 10.1016/S2666-7568(22)00097-6. Epub 2022 Jun 9.

  PMID: 36098317 BACKGROUND

Related Links

• WHO's report on findings from implementing ICOPE pilots in different countries

MeSH Terms

Conditions

Patient Acceptance of Health Care

Condition Hierarchy (Ancestors)

Treatment Adherence and Compliance; Health Behavior; Behavior

Study Officials

• Ninie Wang, MBA DrPH

  Pinetree Care Group

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 6, 2023
• First Posted: July 6, 2023
• Study Start: September 1, 2020
• Primary Completion: July 31, 2021
• Study Completion: August 31, 2021
• Last Updated: July 6, 2023

Record last verified: 2023-07

Data Sharing

• IPD Sharing: Will not share

Locations

CN (1)